Advertisement

Number and Characteristics of US Adults Meeting Prediabetes Criteria for Diabetes Prevention Programs: NHANES 2007–2016

  • Alexandra K. Lee
  • Bethany Warren
  • Caroline Liu
  • Kathryn Foti
  • Elizabeth SelvinEmail author
Concise Research Reports

INTRODUCTION

Type 2 diabetes is a major public health challenge but can be prevented. The landmark Diabetes Prevention Program (DPP) Trial demonstrated a 58% reduction in 3-year diabetes incidence with an intensive lifestyle intervention in high-risk persons with prediabetes.1 There is substantial interest in translating this program to community settings. In 2010, the Centers for Disease Control and Prevention created a partnership called the National Diabetes Prevention Program (National DPP) and developed a set of guidance documents and steps for national certification of local lifestyle change programs.2 In 2018, the Centers for Medicare and Medicaid Services began providing insurance coverage for Medicare beneficiaries meeting Medicare DPP criteria to attend recognized DPPs.3As is typical for research translation, community-based programs that are part of the National DPP use less restrictive eligibility criteria than the original DPP Trial. The Medicare DPP model was certified...

Notes

Acknowledgements

The authors thank NHANES staff and participants.

Author Contributions

A.K. Lee and B. Warren conceived and designed the study. A.K. Lee and C. Liu conducted statistical analysis and drafted the manuscript. B. Warren contributed to the interpretation of data and drafting the manuscript. K. Foti and E. Selvin provided supervision and contributed to the interpretation of the data and the revision of the manuscript for critical intellectual content. All authors had final approval of the version submitted for publication. E. Selvin is the guarantor of this work.

Funding

B. Warren, A.K. Lee, and K. Foti were supported by NIH/NHLBI grant T32HL007024. E. Selvin was supported by NIH/NIDDK grant K24DK106414.

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they do not have a conflict of interest.

Role of the Funding Source

The funding source had no role in data analysis, drafting the manuscript, or the decision to submit the manuscript for publication.

References

  1. 1.
    Diabetes Prevention Program Research Group. Reduction in the Incidence of Type 2 Diabetes With Lifestyle Intervention or Metformin. N Engl J Med. 2002;346(6):393–403.CrossRefGoogle Scholar
  2. 2.
    Centers for Disease Control and Prevention. Diabetes Prevention Recognition Program: Standards and Operating Procedures, March 1, 2018. Available at: https://www.cdc.gov/diabetes/prevention/pdf/dprp-standards.pdf. Accessed December 19, 2018.
  3. 3.
    Centers for Medicare and Medicaid Services. Medicare Diabetes Prevention Program (MDPP) Expanded Model. Available at: https://innovation.cms.gov/initiatives/medicare-diabetes-prevention-program/. Accessed December 19, 2018.
  4. 4.
    Department of Health and Human Services. Certification of Medicare Diabetes Prevention Program. Available at: https://www.cms.gov/Research-Statistics-Data-and-Systems/Research/ActuarialStudies/Downloads/Diabetes-Prevention-Certification-2016-03-14.pdf Accessed Oct 17, 2018.
  5. 5.
    Orchard TJ, Temprosa M, Barrett-Connor E, et al. Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: A report from the DPP Outcomes Study. Diabet Med. 2013;30(1):46–55.CrossRefGoogle Scholar
  6. 6.
    Joiner KL, Nam S, Whittemore R. Lifestyle interventions based on the diabetes prevention program delivered via eHealth: A systematic review and meta-analysis. Prev Med. 2017;100:194–207.CrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2019

Authors and Affiliations

  • Alexandra K. Lee
    • 1
  • Bethany Warren
    • 1
  • Caroline Liu
    • 1
  • Kathryn Foti
    • 1
  • Elizabeth Selvin
    • 1
    Email author
  1. 1.Department of Epidemiology and the Welch Center for Prevention, Epidemiology and Clinical ResearchJohns Hopkins Bloomberg School of Public HealthBaltimoreUSA

Personalised recommendations